Page 92

Febrero 2017

art ículo de revisi ón Terapia simbiótica en pacientes infectados con VIH-1 - M. G. Feria et al 38. Sheih Y, Chiang B, Wang L, Liao C, Gill H. Systemic immunity 228 enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr 2001; 20 (2 Suppl): 149-56. 39. Kengatharan M, De Kimpe SJ, Thiemermann C. Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Br J Pharmacol 1996; 117 (6): 1163-70. 40. Okada Y, Tsuzuki Y, Hokari R, Komoto S, Kurihara C, Kawaguchi A, et al. Anti-inflammatory effects of the genus Bifidobacterium on macrophages by modification of phospho-IkB and SOCS gene expression. Int J Exp Pathol 2009; 90 (2): 131-40. 41. Dangond F, Gullans S. Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate. Biochem Biophys Res Commun 1998; 247 (3): 833-7. 42. Peng L, Li Z-R, Green R, Holzman I, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 2009; 139 (9): 1619- 25. 43. Berndt B, Zhang M, Owyang S, Cole TS, Wang T, Luther J, et al. Butyrate increases IL-23 production by stimulated dendritic cells. AJP Gastrointest Liver Physiol 2012; 303 (12): 1384-92. 44. Klampfer L, Huang J, Sasazuki T, Shirasawa S, Augenlicht L. Inhibition of interferon gamma signaling by the short chain fatty acid butyrate. Mol Cancer Res 2003; 1 (11): 855-62. 45. Kiefer J, Beyer-Sehlmeyer G, Pool-Zobel B. Mixtures of SCFA, composed according to physiologically available concentrations in the gut lumen, modulate histone acetylation in human HT29 colon cancer cells. Br J Nutr 2006; 96: 803-10. 46. Maslowski K, Vieira A, Ng A, Kranich J, Sierro F, Yu D, et al. Regulation of inflammatory responses by gut microbiota and chemoattractan receptor GPR43. Nature. 2009;461(7268):1282-6. 47. Frei R, Ferstl R, Konieczna P, Ziegler M, Simon T, Rugeles T, et al. Histamine receptor 2 modifies dendritic cell responses to microbial ligands. J Allergy Clin Immunol. Elsevier Ltd. 2013; 132 (1): 194-204. 48. Jiang W, Sunkara L, Zeng X, Deng Z, Myers S, Zhang G. Differential regulation of human cathelicidin LL-37 by free fatty acids and their analogs. Peptides. Elsevier Inc. 2013; 50: 129-38. 49. Zhang X, Hunt P, Hammer S, Cespedes M, Patterson K, Bosch R. Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment. HIV Clin Trials 2013; 14 (2): 61-7. 50. Gordon SN, Cervasi B, Odorizzi P, Silverman R, Aberra F, Ginsber G, et al. Disruption of Intestinal CD4+ T Cell Homeostasis Is a Key Marker of Systemic CD4+ T Cell Activation in HIV-Infected Individuals. J Immunol 2011; 185 (9): 5169-79. 51. D’Ettorre G, Ceccarelli G, Giustini N, Serafino S, Calantone N, De Girolamo G, et al. Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: Results of the “Probio-HIV” clinical trial. PLoS One 2015; 10 (9): 1-15. 52. Irvine S, Hummelen R, Hekmat S, Looman CW, Habbema JD, Reid G. Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J Clin Gastroenterol 2010; 44 (9): 201-5. 53. Trois L, Cardoso E, Miura E. Use of probiotics in HIV-infected children: A randomized double-blind controlled study. J Trop Pediatr 2008; 54 (1): 19-24. 54. Hummelen R, Changalucha J, Butamanya NL, Koyama T, Cook A, Habbema JDF, et al. Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes 2011; 2 (2): 80-5. 55. Guinane S. The effectiveness of probiotics for managing diarrhoea in people with HIV infection: A critically appraised topic. HIV Med 2013; 14: 187-90. 56. Hemsworth JC, Hekmat S, Reid G. Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada. Gut Microbes 2012; 3 (5): 414-9. 57. Anukam K, Osazuwa E, Osadolor H, Bruce A, Reid G. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol 2008; 42 (3): 239-43. 58. Salminen M, Tynkkynen S, Rautelin H, Poussa T, Saxelin M, Ristola M, et al. The Efficacy and Safety of Probiotic Lactobacillus rhamnosus GG on Prolonged, Noninfectious Diarrhea in HIV Patients on Antiretroviral Therapy: A Randomized, Placebo-Controlled, Crossover Study. HIV Clin Trials 2004; 5 (4): 183-91. 59. Haghighat L, Crum-Cianflone N. The potential risks of probiotics among HIV-infected persons: Bacteraemia due to Lactobacillus acidophilus and review of the literature. Int J STD AIDS Internet 2015; 0 (0): 1-8. Available from: http://std.sagepub.com/lookup/ doi/10.1177/0956462415590725 60. González-Hernández L, Jave-Suárez L, Fafutis-Morris M, Montes-Salcedo K, Valle-Gutiérrez L, Campos-Loza Rev Med Chile 2017; 145: 219-229


Febrero 2017
To see the actual publication please follow the link above